๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Food aversions in children receiving chemotherapy for cancer

โœ Scribed by Ilene L. Bernstein; Mary M. Webster; Irwin D. Bernstein


Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
309 KB
Volume
50
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Pediatric patients receiving cancer chemotherapy formed aversions to familiar foods in their usual diet when these foods were consumed prior to drug treatments. These aversions were evidently learned due to the association of these foods with the symptoms of drug treatment. Some simple intervention procedures may prove effective in preventing the development of these aversions.


๐Ÿ“œ SIMILAR VOLUMES


Clinical implications of learned food av
โœ Richard D. Mattes; Walter J. Curran Jr.; Jane Alavi; William Powlis; Richard Whi ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 822 KB

Background. The nutritional implications of learned food aversions were evaluated in patients with newly diagnosed cancer receiving either chemotherapy (n = 53) or radiation therapy (n = 49). Methods. Aversion incidence was determined by questionnaires and a food challenge. Measures of dietary and

Cancer markers in patients receiving che
โœ Bullen, B. R. ;Cooper, E. H. ;Turner, R. ;Neville, A. M. ;Giles, G. R. ;Hall, R. ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 656 KB

## Abstract The combination of CEA, hepatic function marker enzymes, and four acute phase reactant proteins (haptoglobin, ฮฑ~1~ antitrypsin, ฮฑ~1~ acid glycoprotein, and prealbumin) has been used to monitor patients with colorectal cancer receiving chemotherapy. In 18 patients with advanced lesions

Home chemotherapy for children with canc
โœ S. Jayabose; V. Escobedo; O. Tugal; A. Nahaczewski; P. Donohue; V. Fuentes; G. D ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 555 KB
Assessment of systemic toxicity in child
โœ Theis, Jochen G.W.; Chan, Helen S.L.; Greenberg, Mark L.; Malkin, David; Karasko ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 113 KB ๐Ÿ‘ 2 views

Background. Overexpression of P-glycoprotein in malignant tumors has been associated with poor responses to chemotherapy. It appears biologically plausible that addition of the P-glycoprotein inhibitor cyclosporine (CsA) to standard chemotherapy may improve the outcome. The protective functions of P